Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

NCT01472614 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Type-2 Diabetes Mellitus

Interventions

DRUG: DLBS3233

Sponsor

Dexa Medica Group